A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis
Clinical trial NCT04131309 · COMPLETED
Trial details
- NCT number
- NCT04131309
- Sponsor
- Stichting European Myeloma Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-23
- Primary completion
- 2025-01-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.